A randomized control trial to assess the role of Camylofin Dihydrochloride in acceleration of active phase of labour in tertiary care hospital
Phase 4
Completed
- Conditions
- Health Condition 1: O30-O48- Maternal care related to the fetus and amniotic cavity and possible delivery problems
- Registration Number
- CTRI/2022/10/046883
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 114
Inclusion Criteria
primigravidas in age group of 18-35 years with gestational age of 37-40 weeks with singleton foetus in vertex presentation, in active phase of labour. (Active phase of labour- 5cm or more cervical dilatation with uterine contractions.
Exclusion Criteria
any antenatal pregnancy complications like preeclampsia, eclampsia , suspected cephalopelvic disproportion, premature rupture of membranes, placenta previa, abruptio placenta, abnormal presentation, preterm labour, multiple pregnancy and patients requiring induction or use of any oxytocic drugs and any other medical disorders like diabetes, cardiac, renal and hepatic disorders. Known hypersensitivity to drugs will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method